Churchill Downs Court Win Offers Minor Relief Amid Larger Financial Strains

What happened

Churchill Downs announced a U.S. District Court victory, ruling the Horseracing Integrity and Safety Authority's purse-weighted fee methodology unlawful and potentially reducing regulatory costs. This legal outcome provides some fee relief, but it does not address the core financial pressures highlighted in the DeepValue report, where net debt/EBITDA stands at 4.44x and credit ratings are BB- due to slow deleveraging. The company's investment thesis hinges on deleveraging through capex normalization to under $200M in 2026 and stabilizing Virginia Historical Racing Machine venues amid consumer softness. Near-term catalysts, such as FY2025 results for leverage guidance and Casino Salem's redevelopment timeline, remain critical for assessing operational progress. Consequently, while the court decision is positive, it is overshadowed by the need for disciplined capital allocation and proof of ramp economics to shift the 'WAIT' rating.

Implication

Investors should see the legal win as a slight positive that may lower future fee expenses, potentially freeing up minor cash flow for debt reduction or other uses. However, CHDN's elevated leverage at 4.44x net debt/EBITDA remains a key constraint, with S&P downgrading to BB- due to expectations of slow deleveraging, compounded by continued buybacks and acquisitions. The company must still deliver on capex normalization to $160–$200M in 2026 and achieve net leverage below 4.0x, as guided, to improve financial flexibility and credit metrics. Operational challenges in Virginia, such as weak unrated play at HRM venues, require stabilization to support EBITDA growth and validate the expansion strategy. Therefore, the court outcome does not substitute for the upcoming milestones—FY2025 results, Salem closure progress, and Kentucky Oaks performance—that are essential for confirming deleveraging and ramp success before reconsidering the investment stance.

Thesis delta

The court ruling is a favorable development that could reduce regulatory costs and slightly improve cash flow, but it does not materially alter the investment thesis centered on deleveraging and Virginia HRM stabilization. No shift from the 'WAIT' rating is justified until evidence from key catalysts, such as FY2025 guidance and operational updates, confirms meaningful progress on leverage reduction and ramp economics.